ClinicalTrials.gg
Active, not recruitingNCT06272318Updated Sep 30, 2026

Vital Signs Blood Pressure Trial

An observational study in Cardiovascular Diseases, Hypertension and Blood Pressure, sponsored by Stanford University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.

Primary conditionHypertensionRegistry: Cardiovascular DiseasesReclassifiedWhy we changed it
Registry
Cardiovascular Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hypertension
Why
  1. The study's listed conditions name Hypertension, a narrower term within Cardiovascular Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Stanford University · Observational

How we know

Updated Sep 30, 2026Now Active, not recruitingFirst site in United States+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Hypertension by Stanford University — 1 open to participants now, 2 under way, none of them phase 3. Hypertension · Stanford University.

Started
2026
the only one that year
Observational
3 of 18
none open now
Registered
18th of 18
by date

Among the 18 studies in Hypertension by Stanford University, this one is the only one that started in 2026, is one of 3 observational ones, and was the 18th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

1 of the 18 studies in Hypertension by Stanford University is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years to 64 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Hypertension by Stanford University, or all of them as a file.
02

Study summary

The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device.

03

Conditions studied

  • Cardiovascular Diseases
  • Hypertension
  • Blood Pressure

Browse trials for

04

In context

Hypertension Reclassified

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

This study's planned enrollment of 50 is below the median of 352 across 1,166 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.

Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.

Compared within Hypertension, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Cardiovascular Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants with a range of health conditions are needed for this study, including those with cardiac or blood pressure issues, as well as individuals who are considered healthy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >17 and \<65 years
  • >20 and \<35

Exclusion criteria

Exclusion Criteria:

  • Age \<18 or >64
  • \<20 or >35
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Interventions

  • OtherBlood Pressure Cuff, EKG, PPG

    A blood pressure cuff, an EKG, and a PPG will be utilized to collect subject vitals.

07

What researchers measure

Primary outcomes

  1. Collection of Subject Name (optional)

    Time frame: Less than 1 minute

  2. Collection of Subject Height

    Height in meters

    Time frame: Less than 1 minute

  3. Collection of Subject Weight

    Weight in kilograms

    Time frame: Less than 1 minute

  4. Collection of Subject Age

    Age in years

    Time frame: Less than 1 minute

  5. Collection of Subject Medical Comorbidities

    Time frame: 1 minute

  6. Systolic and Diastolic Blood Pressure Measurement

    Using blood pressure cuff; measured three times to find the initial, interim, and final blood pressure

    Time frame: 1-2 minutes

  7. Collection of ECG Waveforms

    Using an electrocardiogram (ECG) to measure heart rhythm

    Time frame: 5 minutes

  8. Collection of PPG Waveforms

    Using a photoplethysmography (PPG) to monitor heart rate

    Time frame: 5 minutes

08

Study locations

1 site
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Aug 2026, 3 months.

Of 348 non-industry observational studies under Hypertension, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 111. This study's 3 months is below that.

Counting every sponsor, half of 429 studies reached it within 38 months; a quarter within 17 and three quarters within 96.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Sep 2026 → Aug 2026 and completion Sep 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2024
First posted
Feb 22, 2024
StartActual
May 4, 2026
Primary completionActual
Aug 28, 2026was Sep 2026
CompletionEst.
Dec 30, 2026was Sep 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Active, not recruiting
changed Sep 30, 2026
Sites
1 site added — first site in United States
Show site
  • Stanford University · Stanford, United States
Sep 30, 2026
Start date
May 1, 2026→May 4, 2026 (actual)
Sep 30, 2026
Primary completion
Sep 30, 2026→Aug 28, 2026 (actual)
Sep 30, 2026
Study completion
Sep 30, 2026→Dec 30, 2026
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Not yet recruiting→Active, not recruiting
    1 site added — first site in United States
    Show site
    • Stanford University · Stanford, United States
    Start date May 1, 2026→May 4, 2026 (now actual)
    Primary completion Sep 30, 2026→Aug 28, 2026 (now actual)
    Study completion Sep 30, 2026→Dec 30, 2026
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06272318
Responsible party
Alexandra Ruan (Principal Investigator, Stanford University) — Principal investigator
First posted
Feb 22, 2024
Start date
May 4, 2026
Primary completion
Aug 28, 2026
Completion
Dec 30, 2026 (estimated)
Last update
Sep 30, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion